The Health Policy Partnership (HPP) has published a think piece setting out the current situation of lung cancer treatment and care in Europe, and outlining strategic priorities for governments to focus on.
Lung cancer remains the leading cause of cancer-related deaths in Europe, and while considerable advances have been made in diagnosis and care, there are significant barriers to access to appropriate services. We make the case that to improve diagnosis and treatment, access to screening programmes and high-quality care must be expanded.
HPP authored the think piece Lung cancer in Europe: the way forward in collaboration with expert co-authors from the National Institute of Public Health of Slovenia, Lung Cancer Europe, the Medical University of Gdańsk, the Global Lung Cancer Coalition, Women Against Lung Cancer in Europe, the European Network for Smoking and Tobacco Prevention and the European Respiratory Society.
The report highlights four key areas that governments need to address in order to improve the quality of life and outcomes for people with lung cancer. These are:
- Increasing awareness of lung cancer and reducing stigma linked to smoking.
- Improving early diagnosis by accelerating the implementation of targeted screening programmes.
- Reducing inequalities in access and outcomes.
- Improving the availability of high-quality, multidisciplinary care.
Download the think piece
HPP will discuss the findings from the think piece during the webinar Building a comprehensive approach to lung cancer in Europe. The free webinar will take place tomorrow at 10:00–11.30 CET.
The webinar will feature a panel of European lung cancer experts and decision-makers, including authors of the think piece.
Find out more on the project page.